
Deepline Pharma Private Limited
About Deepline Pharma Private Limited
Data last updated:
Deepline Pharma Private Limited is a private limited company based in Delhi, India. It operates in the building installation and fitting segment of the construction sector. It was incorporated on 18 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U45309DL2021PTC375788.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jyoti Rawat and Vijay Kumar Rawat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 146 Kilokari, Delhi, India – 110014.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.89 Lakh. For the same year it recorded a net loss of ₹29.1 Lakh (net margin -127.1%) and EBITDA of -₹29.1 Lakh (EBITDA margin -127.1%).
Company details
Contact details
Deepline Pharma Private Limited's registered office is in Delhi, Delhi.
- Registered AddressC – 146 Kilokari, Delhi, India – 110014
- IndustryConstruction, Other Building Installation, Building Installation
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Deepline Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Deepline Pharma Private Limited, buy the company report.
Financials of Deepline Pharma Private Limited
FY 2025 filings availableDeepline Pharma Private Limited reported revenue of ₹22.89 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹29.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹29.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -127.1% | ||||
| Net Profit Margin | -127.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Deepline Pharma Private Limited, buy the company report.
Board of directors of Deepline Pharma Private Limited
Deepline Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jyoti Rawat | Director | 09 Mar 2023 | 3 Years 8 Months | Current |
| Vijay Kumar Rawat | Director | 18 Jan 2021 | 5 Years 10 Months | Current |
Peer comparison
Deepline Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ista Life Care Private Limited | ₹23.81 Lakh (FY 2025) | 124.0% | Sangareddy, Telangana, India | |||
| Erotas Life Sciences Private Limited | ₹23.79 Lakh (FY 2025) | Hyderabad, Telangana, India | ||||
| Jan Med India Pharma Private Limited | ₹23.22 Lakh (FY 2025) | 70.0% | Erode, Tamil Nadu, India | |||
| Terveysliv Pharmaceuticals Private Limited | ₹23.2 Lakh (FY 2025) | Surat, Gujarat, India | ||||
| Phytoveda Private Limited | ₹23.17 Lakh (FY 2025) | 167.0% | Mumbai, Maharashtra, India | |||
| Deepline Pharma Private Limitedthis company | ₹22.89 Lakh (FY 2025) | -₹29.1 Lakh | -127.1% | Delhi, India | ||
| Goyal Industrial Park Private Limited | ₹22.62 Lakh (FY 2024) | -40.0% | Jaipur, Rajasthan, India | |||
| Navante Pharmaceuticals Private Limited | ₹22.6 Lakh (FY 2025) | Vijayawada, Andhra Pradesh, India | ||||
| Dugen Pharma Private Limited | ₹22.51 Lakh (FY 2025) | -74.0% | Pune, Maharashtra, India | |||
| Rankan Biological Private Limited | ₹22.38 Lakh (FY 2025) | 0.0% | Delhi, India | |||
| PSK Biotech Private Limited | ₹22.36 Lakh (FY 2024) | 4025.0% | Dehradun, Uttarakhand, India |
To see the full peer comparison of Deepline Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Deepline Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Deepline Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Deepline Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Deepline Pharma Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Jyoti Rawat was appointed as Director on 09 Mar 2023.
Frequently asked questions
Deepline Pharma is an active private limited company based in Delhi, India. The company works in other building installation, within the construction industry. It was incorporated on 18 January 2021 (5+ years old) and is registered under CIN U45309DL2021PTC375788.
Deepline Pharma has 2 current directors:
- Jyoti Rawat - Director
- Vijay Kumar Rawat - Director
The latest financial statements of Deepline Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Deepline Pharma is U45309DL2021PTC375788. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Deepline Pharma was incorporated on 18 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Deepline Pharma by revenue are Ista Life Care Private Limited, Erotas Life Sciences Private Limited, Jan Med India Pharma Private Limited, Terveysliv Pharmaceuticals Private Limited, Phytoveda Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Jyoti Rawat was appointed as Director on 09 Mar 2023. Vipin Bali ceased to be Director on 09 Mar 2023. Vijay Kumar Rawat was appointed as Director on 18 Jan 2021.
The registered office of Deepline Pharma is at C – 146 Kilokari, Delhi, India – 110014.
Deepline Pharma operates in the construction industry, in the other building installation segment.
Deepline Pharma can be reached at its registered office: C – 146 Kilokari, Delhi, India – 110014.
Deepline Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

